Furthermore, in the present study, we observed interactions between simvastatin, AT1 antagonists, and ROCK inhibitors in the substantia nigra and striatum of rats with LID, which may explain why the three treatments reduce dyskinesia. The gene discussed is AGTR1; the disease is drug-induced dyskinesia.